Review



antippp2r1a  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech antippp2r1a
    Antippp2r1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A+Antibody/pm41337753-56-54-55
    Average 93 stars, based on 16 article reviews
    antippp2r1a - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: TurboID Screening of the OmpP2 Protein Reveals Host Proteins Involved in Recognition and Phagocytosis of Glaesserella parasuis by iPAM Cells
    Article Snippet: PPP2R1A , PPP2R1A rabbit polyclonal Ab , Proteintech , 15882-1-AP.

    Incubation:

    Article Title: LncRNA-NONHSAT192404.1 Regulates miR-518a-3p to Inhibit Triple-Negative Breast Cancer Progression via the PI3K/AKT Pathway
    Article Snippet: Equal protein amounts (30 μg) were resolved by SDS-PAGE on 4–20 % gradient gels (Bio-Rad, USA, Catalog No. 4561094) and transferred by wet transfer to PVDF membranes (Millipore, USA, Catalog No. IPVH00010). .. Membranes were blocked with 5 % non-fat milk in TBST (Cell Signaling Technology, Catalog No. 9997S) for 1 h and incubated overnight at 4 ◦C with primary antibodies (1:1000): TLR4 (Proteintech, 19811-1-AP), AKT (Proteintech, 10176-2- AP), PI3K (Proteintech, 27921-1-AP), PPP2R1A (Proteintech, 15882-1-AP), and GAPDH (Proteintech, 10494-1-AP). .. After washing, membranes were incubated with HRP-conjugated secondary antibodies (Cell Signaling Technology, Catalog No. 7074S; 1:2000) for 1 h at room temperature.



    Similar Products

    94
    ABclonal Biotechnology ppp2r1a
    BRG1 promoted Smad3 phosphorylation by regulating <t>Ppp2r1a</t> transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.
    Ppp2r1a, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A+Rabbit+pAb/pmc13033632-76-7-8
    Average 94 stars, based on 1 article reviews
    ppp2r1a - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Sanying Ltd anti ppp2r1a antibody
    BRG1 promoted Smad3 phosphorylation by regulating <t>Ppp2r1a</t> transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.
    Anti Ppp2r1a Antibody, supplied by Sanying Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/anti+ppp2r1a/pm41802576-132-12-14
    Average 86 stars, based on 1 article reviews
    anti ppp2r1a antibody - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti ppp2r1a antibody
    BRG1 promoted Smad3 phosphorylation by regulating <t>Ppp2r1a</t> transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.
    Anti Ppp2r1a Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/pm41673675-98-0-6
    Average 86 stars, based on 1 article reviews
    anti ppp2r1a antibody - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Proteintech antippp2r1a
    BRG1 promoted Smad3 phosphorylation by regulating <t>Ppp2r1a</t> transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.
    Antippp2r1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A+Antibody/pm41337753-56-54-55
    Average 93 stars, based on 1 article reviews
    antippp2r1a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Proteintech ppp2r1a
    BRG1 promoted Smad3 phosphorylation by regulating <t>Ppp2r1a</t> transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.
    Ppp2r1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A+Antibody/10__15419_slash_8z52aw42-95-39-40
    Average 93 stars, based on 1 article reviews
    ppp2r1a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    91
    Cusabio ppp2r1a
    Fig. 6. AKR1B10K125L impedes PP2A assembly to drive CRC metastasis. (A) Schematic representation of AKR1B10 truncations and Co-IP analysis of Flag-tagged AKR1B10 truncations in HCT116 cells, as indicated. FL, full length. (B) Computational docking model predicting the interaction between AKR1B10 (red) and PP2A (purple) using the Global RAnge Molecular Matching (GRAMM) algorithm. (C) Co-IP analysis showing the interaction between PPP2CA with AKR1B10WT, AKR1B10K125L, AKR1B- 10P219S, and AKR1B10K263R in HCT116 cells, using an anti-HA antibody. (D and E) Recombinant GST-tagged AKR1B10 (WT or K125L) was incubated with His-PPP2CA (D) or <t>His-PPP2R1A</t> (E). Bound proteins were analyzed by Western blot. Data are representative of three independent experiments. (F) Representative FACS images and quanti- fication of intracellular ROS levels in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (G) Alignment of K125 and C299 amino acid residues in AKR1B10 across multiple species. H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus; P. troglodytes, Pan troglodytes; M. mulatta, Macaca mulatta. (H) Co-IP analysis of PPP2R5A demonstrating increased 3-NT and reduced PPP2CA interaction in AKR1B10K125L and AKR1B10C299S overexpressing HCT116-shAKR1B10 cells. (I) Western blot analysis of c-Myc, phospho-Myc (p-Myc), and ITGB8 protein expression in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (J and K) Representative images (left) and quantification (right) of transwell assay (J), and relative PP2A activity (K) in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (L to O) Representative images (L) and quantification (M) of liver metastatic nodules in nude mice following splenic injection of HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, and AKR1B10K125L. Representative H&E staining and IHC images of AKR1B10, ITGB8, and c-Myc staining in liver sections (N), with quantified histoscores (O) (n = 5 mice per group). (F, J, and K) n = 3. Data in (F), (J), (K), (M), and (O) are presented as mean ± SD, with unpaired Student’s t test. *P < 0.05, **P < 0.01, and ***P < 0.001.
    Ppp2r1a, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A/10__1126_slash_sciadv__adv6937-305-12-13
    Average 91 stars, based on 1 article reviews
    ppp2r1a - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    91
    Cusabio his ppp2r1a
    Fig. 6. AKR1B10K125L impedes PP2A assembly to drive CRC metastasis. (A) Schematic representation of AKR1B10 truncations and Co-IP analysis of Flag-tagged AKR1B10 truncations in HCT116 cells, as indicated. FL, full length. (B) Computational docking model predicting the interaction between AKR1B10 (red) and PP2A (purple) using the Global RAnge Molecular Matching (GRAMM) algorithm. (C) Co-IP analysis showing the interaction between PPP2CA with AKR1B10WT, AKR1B10K125L, AKR1B- 10P219S, and AKR1B10K263R in HCT116 cells, using an anti-HA antibody. (D and E) Recombinant GST-tagged AKR1B10 (WT or K125L) was incubated with His-PPP2CA (D) or <t>His-PPP2R1A</t> (E). Bound proteins were analyzed by Western blot. Data are representative of three independent experiments. (F) Representative FACS images and quanti- fication of intracellular ROS levels in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (G) Alignment of K125 and C299 amino acid residues in AKR1B10 across multiple species. H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus; P. troglodytes, Pan troglodytes; M. mulatta, Macaca mulatta. (H) Co-IP analysis of PPP2R5A demonstrating increased 3-NT and reduced PPP2CA interaction in AKR1B10K125L and AKR1B10C299S overexpressing HCT116-shAKR1B10 cells. (I) Western blot analysis of c-Myc, phospho-Myc (p-Myc), and ITGB8 protein expression in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (J and K) Representative images (left) and quantification (right) of transwell assay (J), and relative PP2A activity (K) in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (L to O) Representative images (L) and quantification (M) of liver metastatic nodules in nude mice following splenic injection of HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, and AKR1B10K125L. Representative H&E staining and IHC images of AKR1B10, ITGB8, and c-Myc staining in liver sections (N), with quantified histoscores (O) (n = 5 mice per group). (F, J, and K) n = 3. Data in (F), (J), (K), (M), and (O) are presented as mean ± SD, with unpaired Student’s t test. *P < 0.05, **P < 0.01, and ***P < 0.001.
    His Ppp2r1a, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A/pmc12372902-258-9-10
    Average 91 stars, based on 1 article reviews
    his ppp2r1a - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    93
    Proteintech anti ppp2r1a
    Fig. 6. AKR1B10K125L impedes PP2A assembly to drive CRC metastasis. (A) Schematic representation of AKR1B10 truncations and Co-IP analysis of Flag-tagged AKR1B10 truncations in HCT116 cells, as indicated. FL, full length. (B) Computational docking model predicting the interaction between AKR1B10 (red) and PP2A (purple) using the Global RAnge Molecular Matching (GRAMM) algorithm. (C) Co-IP analysis showing the interaction between PPP2CA with AKR1B10WT, AKR1B10K125L, AKR1B- 10P219S, and AKR1B10K263R in HCT116 cells, using an anti-HA antibody. (D and E) Recombinant GST-tagged AKR1B10 (WT or K125L) was incubated with His-PPP2CA (D) or <t>His-PPP2R1A</t> (E). Bound proteins were analyzed by Western blot. Data are representative of three independent experiments. (F) Representative FACS images and quanti- fication of intracellular ROS levels in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (G) Alignment of K125 and C299 amino acid residues in AKR1B10 across multiple species. H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus; P. troglodytes, Pan troglodytes; M. mulatta, Macaca mulatta. (H) Co-IP analysis of PPP2R5A demonstrating increased 3-NT and reduced PPP2CA interaction in AKR1B10K125L and AKR1B10C299S overexpressing HCT116-shAKR1B10 cells. (I) Western blot analysis of c-Myc, phospho-Myc (p-Myc), and ITGB8 protein expression in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (J and K) Representative images (left) and quantification (right) of transwell assay (J), and relative PP2A activity (K) in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (L to O) Representative images (L) and quantification (M) of liver metastatic nodules in nude mice following splenic injection of HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, and AKR1B10K125L. Representative H&E staining and IHC images of AKR1B10, ITGB8, and c-Myc staining in liver sections (N), with quantified histoscores (O) (n = 5 mice per group). (F, J, and K) n = 3. Data in (F), (J), (K), (M), and (O) are presented as mean ± SD, with unpaired Student’s t test. *P < 0.05, **P < 0.01, and ***P < 0.001.
    Anti Ppp2r1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PPP2R1A+Antibody/pmc12404745__jci-135-185602-s304-207-41-43
    Average 93 stars, based on 1 article reviews
    anti ppp2r1a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mouse monoclonal anti ppp2r1a b
    Fig. 6. AKR1B10K125L impedes PP2A assembly to drive CRC metastasis. (A) Schematic representation of AKR1B10 truncations and Co-IP analysis of Flag-tagged AKR1B10 truncations in HCT116 cells, as indicated. FL, full length. (B) Computational docking model predicting the interaction between AKR1B10 (red) and PP2A (purple) using the Global RAnge Molecular Matching (GRAMM) algorithm. (C) Co-IP analysis showing the interaction between PPP2CA with AKR1B10WT, AKR1B10K125L, AKR1B- 10P219S, and AKR1B10K263R in HCT116 cells, using an anti-HA antibody. (D and E) Recombinant GST-tagged AKR1B10 (WT or K125L) was incubated with His-PPP2CA (D) or <t>His-PPP2R1A</t> (E). Bound proteins were analyzed by Western blot. Data are representative of three independent experiments. (F) Representative FACS images and quanti- fication of intracellular ROS levels in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (G) Alignment of K125 and C299 amino acid residues in AKR1B10 across multiple species. H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus; P. troglodytes, Pan troglodytes; M. mulatta, Macaca mulatta. (H) Co-IP analysis of PPP2R5A demonstrating increased 3-NT and reduced PPP2CA interaction in AKR1B10K125L and AKR1B10C299S overexpressing HCT116-shAKR1B10 cells. (I) Western blot analysis of c-Myc, phospho-Myc (p-Myc), and ITGB8 protein expression in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (J and K) Representative images (left) and quantification (right) of transwell assay (J), and relative PP2A activity (K) in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (L to O) Representative images (L) and quantification (M) of liver metastatic nodules in nude mice following splenic injection of HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, and AKR1B10K125L. Representative H&E staining and IHC images of AKR1B10, ITGB8, and c-Myc staining in liver sections (N), with quantified histoscores (O) (n = 5 mice per group). (F, J, and K) n = 3. Data in (F), (J), (K), (M), and (O) are presented as mean ± SD, with unpaired Student’s t test. *P < 0.05, **P < 0.01, and ***P < 0.001.
    Mouse Monoclonal Anti Ppp2r1a B, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ppp2r1a/PP2A-A%CE%B1%2F%CE%B2+Antibody/pmc12296510-7-0-5
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti ppp2r1a b - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    BRG1 promoted Smad3 phosphorylation by regulating Ppp2r1a transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.

    Journal: Frontiers in Pharmacology

    Article Title: BRG1 exacerbates myocardial fibrosis after myocardial infarction by interacting with ZEB1

    doi: 10.3389/fphar.2026.1802700

    Figure Lengend Snippet: BRG1 promoted Smad3 phosphorylation by regulating Ppp2r1a transcription. (A) Western blot analysis of p-Smad3 and t-Smad3 protein levels in CFs following co-transfection with BRG1 and siZEB1. *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (B) Immunofluorescence staining reveals the nuclear translocation of Smad3 in CFs. Smad3 (green) and nuclei (DAPI, blue) were labeled. Scale bar = 25 μm. (C,D) Western blot analysis of Col-I and FN1 protein levels in CFs treated with OA following co-transfection with BRG1 overexpression plasmids and siZEB1. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6. (E) In primary mouse fibroblasts with siBRG1, qRT-PCR was employed to evaluate PP2A subunit ( Ppp2ca , Ppp2cb , Ppp2r1a , Ppp2r1b , Ppp2r2a , Ppp2r2b , Ppp2r2c , Ppp2r2d , Ppp2r3a ) mRNA expression. ** p < 0.01 vs. NC group by a two-tailed Student’s t-test. n = 4. (F) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siZEB1. *** p < 0.001 vs. NC group. (G) Luciferase reporter assay of Ppp2r1a promoter activity in CFs transfected with siBRG1. *** p < 0.001 vs. NC group. (H) Luciferase reporter assay of Ppp2r1a promoter activity in CFs co-transfected with BRG1 overexpression plasmid and siZEB1 *** p < 0.001 vs. Ctl group or BRG1+NC group by one-way ANOVA followed by Tukey’s post hoc analysis. n = 10. (I) ChIP analysis identified ZEB1 binding sites in the Ppp2r1a promoter region. (J) ChIP-qPCR analysis of BRG1 and ZEB1 binding to the Ppp2r1a promoter region in CFs. * p < 0.05 and ** p < 0.01 vs. IgG. n = 3. (K) Transfection efficiency of siPpp2r1a was detected by Western blot, *** p < 0.001 vs. NC group by a two-tailed Student’s t-test. n = 6. (L) Immunofluorescence detects nuclear translocation of Smad3 (green) in CFs, with DAPI (blue) marking nuclei. Scale bar = 25 μm. (M,N) Representative Western blotting analysis of t-Smad3 protein level in cytoplasm and nucleus in CFs. β-actin was used as the loading control for cytosolic fractions. Histone3 was used as the loading control for nuclear fractions. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated groups by one-way ANOVA followed by Tukey’s post hoc analysis. n = 6.

    Article Snippet: For absolute specificity, ZEB1 (Wanleibio, China, 1:1,000), Ppp2r1a (ABclonal, China, 1:1,000), phospho-Smad3 (Affinity, China, 1:500), and total Smad3 (Affinity, China, 1:500) were probed on separate membranes.

    Techniques: Phospho-proteomics, Western Blot, Cotransfection, Immunofluorescence, Staining, Translocation Assay, Labeling, Over Expression, Quantitative RT-PCR, Expressing, Two Tailed Test, Luciferase, Reporter Assay, Activity Assay, Transfection, Plasmid Preparation, Binding Assay, ChIP-qPCR, Control

    Schematic diagram depicting the role of BRG1 on cardiac fibrosis. Myocardial infarction upregulates BRG1, which interacts with ZEB1 to form a transcriptional repressor complex. This complex suppresses the expression of Ppp2r1a (encoding the PP2A structural subunit), leading to diminished PP2A activity. Consequently, Smad3 phosphorylation and nuclear translocation are enhanced, driving the transcription of fibrotic genes such as Col-1 and FN1, and ultimately exacerbating myocardial fibrosis.

    Journal: Frontiers in Pharmacology

    Article Title: BRG1 exacerbates myocardial fibrosis after myocardial infarction by interacting with ZEB1

    doi: 10.3389/fphar.2026.1802700

    Figure Lengend Snippet: Schematic diagram depicting the role of BRG1 on cardiac fibrosis. Myocardial infarction upregulates BRG1, which interacts with ZEB1 to form a transcriptional repressor complex. This complex suppresses the expression of Ppp2r1a (encoding the PP2A structural subunit), leading to diminished PP2A activity. Consequently, Smad3 phosphorylation and nuclear translocation are enhanced, driving the transcription of fibrotic genes such as Col-1 and FN1, and ultimately exacerbating myocardial fibrosis.

    Article Snippet: For absolute specificity, ZEB1 (Wanleibio, China, 1:1,000), Ppp2r1a (ABclonal, China, 1:1,000), phospho-Smad3 (Affinity, China, 1:500), and total Smad3 (Affinity, China, 1:500) were probed on separate membranes.

    Techniques: Expressing, Activity Assay, Phospho-proteomics, Translocation Assay

    Fig. 6. AKR1B10K125L impedes PP2A assembly to drive CRC metastasis. (A) Schematic representation of AKR1B10 truncations and Co-IP analysis of Flag-tagged AKR1B10 truncations in HCT116 cells, as indicated. FL, full length. (B) Computational docking model predicting the interaction between AKR1B10 (red) and PP2A (purple) using the Global RAnge Molecular Matching (GRAMM) algorithm. (C) Co-IP analysis showing the interaction between PPP2CA with AKR1B10WT, AKR1B10K125L, AKR1B- 10P219S, and AKR1B10K263R in HCT116 cells, using an anti-HA antibody. (D and E) Recombinant GST-tagged AKR1B10 (WT or K125L) was incubated with His-PPP2CA (D) or His-PPP2R1A (E). Bound proteins were analyzed by Western blot. Data are representative of three independent experiments. (F) Representative FACS images and quanti- fication of intracellular ROS levels in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (G) Alignment of K125 and C299 amino acid residues in AKR1B10 across multiple species. H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus; P. troglodytes, Pan troglodytes; M. mulatta, Macaca mulatta. (H) Co-IP analysis of PPP2R5A demonstrating increased 3-NT and reduced PPP2CA interaction in AKR1B10K125L and AKR1B10C299S overexpressing HCT116-shAKR1B10 cells. (I) Western blot analysis of c-Myc, phospho-Myc (p-Myc), and ITGB8 protein expression in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (J and K) Representative images (left) and quantification (right) of transwell assay (J), and relative PP2A activity (K) in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (L to O) Representative images (L) and quantification (M) of liver metastatic nodules in nude mice following splenic injection of HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, and AKR1B10K125L. Representative H&E staining and IHC images of AKR1B10, ITGB8, and c-Myc staining in liver sections (N), with quantified histoscores (O) (n = 5 mice per group). (F, J, and K) n = 3. Data in (F), (J), (K), (M), and (O) are presented as mean ± SD, with unpaired Student’s t test. *P < 0.05, **P < 0.01, and ***P < 0.001.

    Journal: Science Advances

    Article Title: AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration

    doi: 10.1126/sciadv.adv6937

    Figure Lengend Snippet: Fig. 6. AKR1B10K125L impedes PP2A assembly to drive CRC metastasis. (A) Schematic representation of AKR1B10 truncations and Co-IP analysis of Flag-tagged AKR1B10 truncations in HCT116 cells, as indicated. FL, full length. (B) Computational docking model predicting the interaction between AKR1B10 (red) and PP2A (purple) using the Global RAnge Molecular Matching (GRAMM) algorithm. (C) Co-IP analysis showing the interaction between PPP2CA with AKR1B10WT, AKR1B10K125L, AKR1B- 10P219S, and AKR1B10K263R in HCT116 cells, using an anti-HA antibody. (D and E) Recombinant GST-tagged AKR1B10 (WT or K125L) was incubated with His-PPP2CA (D) or His-PPP2R1A (E). Bound proteins were analyzed by Western blot. Data are representative of three independent experiments. (F) Representative FACS images and quanti- fication of intracellular ROS levels in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (G) Alignment of K125 and C299 amino acid residues in AKR1B10 across multiple species. H. sapiens, Homo sapiens; M. musculus, Mus musculus; R. norvegicus, Rattus norvegicus; P. troglodytes, Pan troglodytes; M. mulatta, Macaca mulatta. (H) Co-IP analysis of PPP2R5A demonstrating increased 3-NT and reduced PPP2CA interaction in AKR1B10K125L and AKR1B10C299S overexpressing HCT116-shAKR1B10 cells. (I) Western blot analysis of c-Myc, phospho-Myc (p-Myc), and ITGB8 protein expression in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (J and K) Representative images (left) and quantification (right) of transwell assay (J), and relative PP2A activity (K) in HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, AKR1B10K125L, and AKR1B10C299S. (L to O) Representative images (L) and quantification (M) of liver metastatic nodules in nude mice following splenic injection of HCT116 shNC and shAKR1B10 cells expressing mock, AKR1B10WT, and AKR1B10K125L. Representative H&E staining and IHC images of AKR1B10, ITGB8, and c-Myc staining in liver sections (N), with quantified histoscores (O) (n = 5 mice per group). (F, J, and K) n = 3. Data in (F), (J), (K), (M), and (O) are presented as mean ± SD, with unpaired Student’s t test. *P < 0.05, **P < 0.01, and ***P < 0.001.

    Article Snippet: Then, 3 μg of recombinant His- PPP2CA (CusaBio, CSB- EP018559HUc7) or His- PPP2R1A (CusaBio, CSB- EP018562HUa0) was added to the buffer containing protein- bound glutathione beads overnight at 4°C.

    Techniques: Co-Immunoprecipitation Assay, Recombinant, Incubation, Western Blot, Expressing, Transwell Assay, Activity Assay, Injection, Staining